First human trial tests new Drug's safety profile
NCT ID NCT06667765
Summary
This early-stage study tested the safety and how the body processes a new drug called RPT1G in healthy adults. Fifty-six participants received either the drug or a placebo in single or multiple doses over several days. The main goal was to check for side effects and understand how the drug moves through the body, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.